English 
Japanese 
Bioorganic and Medicinal Chemistry Letters, 27, 4705-4709 (2017)
Ueda, Hiroshi; Jun-ichi Kurita; Neyama, Hiroyuki; Hirao, Yuuka; Kouji, Hiroyuki; Mishina, Tadashi; Kasai, Masaji; Nakano, Hirofumi; Yoshimori, Atsushi; Nishimura, Yoshifumi
Archives: News
Establishment of an intermittent cold stress model using Tupaia Belangeri and evaluation of compound C737 targeting neuron-restrictive silencer factor
Experimental Animals, 65(3), 285-292 (2016)
Hai-Ying, Chi; Nagano, Kiori; Ezzikouri, Sayeh; Yamaguchi, Chiho; Kayesh, Mohammad Enamul Hoque; Rebbani, Khadija; Kitab, Bouchra; Nakano, Hirohumi; Kouji, Hiroyuki; Kohara, Michinori; Tsukiyama-Kohara, Kyoko
Follow-up: Prospective compound design using the ‘SAR Matrix’ method and matrix-derived conditional probabilities of activity
F1000Research, 4, 75 (2015)
Gupta-Ostermann, Disha; Hirose, Yoichiro; Odagami, Takenao; Kouji, Hiroyuki; Bajorath, Jurgen
Three-dimensional structural diversity-oriented peptidomimetics based on the cyclopropylic strain
Organic Letters, 15(7), 1686-1689 (2013)
Mizuno, Akira; Miura, Shiho; Watanabe, Mizuki; Ito, Yoshihiko; Yamada, Shizuo; Odagami, Takenao; Kogami, Yuji; Arisawa, Mitsuhiro; Shuto, Satoshi
Protein-Protein Interaction をターゲットとした創薬
Medchem News, 22(1), 21-24 (2012) (Japanese)
Odagami, Takenao; Kouji, Hiroyuki
Deprotection of Nin-formyl group on tryptophan by application of new reagent, 1,2-dimethylethylendiamine in aqueous solution
Advances in Experimental Medicine and Biology, 611, 159-160 (2009)
Odagami, Takenao; Kogami, Yuji; Kouji, Hiroyuki; Tsuda, Yuko; Okada, Yoshio
Identification of new agonists of urotensin-II from a cyclic peptide library
Bioorganic and Medicinal Chemistry, 17, 6742-6747 (2009)
Odagami, Takenao; Tsuda, Yuko; Kogami, Yuji; Kouji, Hiroyuki; Okada, Yoshio
Deprotection of the indole (Nind)-formyl (For) group on tryptophan employing a new reagent, N,N’-dimethylethylendiamine (DMEDA) in an aqueous solution
Chemical and Pharmaceutical Bulletin, 57(2), 211-213 (2009)
Odagami, Takenao; Tsuda, Yuk; Kogami, Yuji; Kouji, Hiroyuki; Okada, Yoshio
Servier and PRISM BioLab enter drug discovery collaboration for a novel target
PRISM BioLab provides PepMetics® (peptide mimetic small molecules) Technology for generating Hit and Lead compounds against Servier’s novel target. Read Full Press Release
PRISM Biolab and Merck enter multi-project drug discovery collaboration
PRISM Biolab provides The PRISM Library, proprietary library of peptide mimetic small molecules for screening against Merck’s novel targets Read Full Press Release